• Exchange: Frankfurt
  • Sector: Health Care
  • Industry: Health Care Facilities & Svcs
  • Sub-Industry: Health Care Services

Response Genetics Inc

+ Add to Watchlist


0.564 EUR 0.0000.00%

As of 02:08:40 ET on 08/21/2014.

Snapshot for Response Genetics Inc (34R)

Open: - Day's Range: - Volume: 0
Previous Close: 0.564 52wk Range: 0.455 - 1.776 1-Yr Rtn: -61.10%

Stock Chart for 34R

No chart data available.
  • 34R:GR 0.564
  • 1M
  • 1Y
Interactive 34R Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 34R

Current P/E Ratio (ttm) -
Estimated P/E(12/2014) -
Relative P/E vs. DAX -
Earnings Per Share (USD) (ttm) -
Est. EPS (USD) (12/2014) -
Est. PEG Ratio -
Market Cap (M EUR) 21.85
Shares Outstanding (M) 38.73
30 Day Average Volume 79
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield -%
Cash Dividend -
Dividend Ex-Date
5 Year Dividend Growth -
Next Earnings Announcement 11/07/2014
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 34R

  • Revenue
  • Net Income (M/USD)
  • Profit Margin (%)

Company Profile & Key Executives for 34R

Response Genetics, Inc. is a biopharmaceutical company that researches and develops pharmacogenomic diagnostic tests. The Company's products are targeted for potential use in the treatment of cancer.

Thomas A Bologna "Tom"Chairman/CEOKevin R HarrisVP/CFO
Stephanie H AstrowVP:Research & DevelopmentAdanech GetachewGeneral Counsel
More Company Profile & Key Executives for 34R

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Sponsored Links
sec ||= nil